ClinicalTrials.gg
CompletedNCT02646150MR CLIUpdated Apr 12, 2023

Clinical Use of Magnetic Resonance Perfusion Imaging to Qualitatively Assess Adequate Distal Perfusion After Endovascular Revascularization in Critical Limb Ischemia

An observational study in Lower Limb, Ischemia and Perfusion, sponsored by Seung-Whan Lee, M.D., Ph.D.. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2023-04-12.

Primary conditionChronic Limb-Threatening IschemiaRegistry: IschemiaReclassifiedWhy we changed it
Registry
Ischemia — the first condition term the registry derived for this study.
ClinicalTrials.gg
Chronic Limb-Threatening Ischemia
Why
  1. The study's title name Chronic Limb-Threatening Ischemia, a narrower term within Ischemia.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Seung-Whan Lee, M.D., Ph.D. · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
65
Ages
20 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Chronic Limb-Threatening Ischemia with a site in Korea, Republic of — 1 open to participants now, 1 under way, none of them phase 3. Chronic Limb-Threatening Ischemia · Korea, Republic of.

Started
2015
the only one that year
Observational
3 of 11
none open now
Registered
6th of 11
by date
Lead sponsor
1 of 11
Seung-Whan Lee, M.D., Ph.D.

Among the 11 studies in Chronic Limb-Threatening Ischemia with a site in Korea, Republic of, this one is the only one that started in 2015, is one of 3 observational ones, and was the 6th registered.

Chronic Limb-Threatening Ischemia

358 studies on the registry are indexed under Chronic Limb-Threatening Ischemia; 73 are open to participants now.

Browse Chronic Limb-Threatening Ischemia studies →

Open to participants now

1 of the 11 studies in Chronic Limb-Threatening Ischemia with a site in Korea, Republic of is open now. Recruiting first, the newest first:

A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →

Who these studies take

Of the 51 Chronic Limb-Threatening Ischemia studies recruiting now, 35 (69%) set no upper age limit and 2 (4%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.

This study: 20 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Chronic Limb-Threatening Ischemia with a site in Korea, Republic of, or all of them as a file.
02

Study summary

This study evaluates the clinical effectiveness of Magnetic Resonance(MR) perfusion imaging to qualitatively assess adequate distal perfusion after endovascular revascularization in Critical Limb Ischemia

03

Conditions studied

  • Lower Limb
  • Ischemia
  • Perfusion

Browse trials for

Keywords

  • Magnetic Resonance perfusion imaging
  • distal perfusion
  • Critical Limb Ischemia
  • endovascular revascularization
04

In context

Chronic Limb-Threatening Ischemia Reclassified

358 studies on the registry are indexed under Chronic Limb-Threatening Ischemia; 73 are open to participants now.

This study's enrollment of 65 is below the median of 111 across 104 observational studies indexed under Chronic Limb-Threatening Ischemia.

Browse Chronic Limb-Threatening Ischemia studies →

Lead sponsor

Seung-Whan Lee, M.D., Ph.D. is the lead sponsor of 5 studies on the registry; 3 are open to participants now.

Compared within Chronic Limb-Threatening Ischemia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Ischemia. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with lower extremity ischemia

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 20 and above
  • Critical limb ischemia with ulcer
  • Ankle brachial index(ABI) ≤ 0.9 or Toe brachial index (TBI) ≤ 0.5 or Transcutaneous oxygen pressure (TcPo2) ≤ 40mmHg
  • ≥ 70 percentage of stenosis of infrapopliteal artery on lower extremity computed tomography angiography or lower extremity doppler
  • Subject understands protocol and provides written,

Exclusion criteria

Exclusion Criteria:

  • Post-traumatic critical limb ischemia
  • Neurogenic limb ischemia
  • ≤ 2 years
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

06

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
65 participants (actual)
Patient registry
No

Groups and cohorts

  • critical limb ischemia

    Procedure: Magnetic Resonance Perfusion Imaging

Interventions

  • ProcedureMagnetic Resonance Perfusion Imaging
07

What researchers measure

Primary outcomes

  1. The change of deoxyhemoglobin in MR imaging

    Time frame: 6 months

Secondary outcomes

  1. The event rate of unplanned major and minor amputation in limb

    Time frame: 6 months

  2. The event rate of complete healing of lower extremity ulcer

    Time frame: 6 months

08

Study locations

1 site
  • Asan Medical Center
    Seoul, Korea, Republic of
09

References and documents

Individual participant data

Plan to share: No — This trial is not publicly funded clinical trial.

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2015 to primary completion in Jul 2021, 67 months.

Of 47 non-industry observational studies under Chronic Limb-Threatening Ischemia, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 60. This study's 67 months is above that.

Counting every sponsor, half of 53 studies reached it within 34 months; a quarter within 22 and three quarters within 59.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 4, 2016
First posted
Jan 5, 2016
StartActual
Dec 12, 2015
Primary completionActual
Jul 13, 2021
CompletionActual
Nov 1, 2021
Last update
Apr 12, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 12, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02646150
Lead sponsor
Seung-Whan Lee, M.D., Ph.D.
Responsible party
Seung-Whan Lee, M.D., Ph.D. (Division of Cardiology, Asan Medical Center) — Sponsor-investigator
First posted
Jan 5, 2016
Start date
Dec 12, 2015
Primary completion
Jul 13, 2021
Completion
Nov 1, 2021
Last update
Apr 12, 2023

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion